Answers are grounded in this paper and cite their sources.
Reports elevated FGF21 levels in metabolically unhealthy obese children, indicating potential biomarker challenges.
FGF21 levels were elevated in children with MUO compared with children with MHO and healthy controls. However, FGF21 does not appear to be a reliable biomarker. Further studies are required to clarify this relationship.
No takes yet. Share an insight, caveat, or question.
Kurşun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: